INSERM
Faculté de Médecine - 11 rue Humann
Strasbourg
Alsace
F - 67095
France
Tel: 33-3-88-24-34-34
Fax: +33-3-88-24-34-35
53 articles about INSERM
-
A multinational research collaboration has developed a new peptide dubbed “PATAS”, which appears to fix the metabolic abnormalities leading to type 2 diabetes (T2D).
-
This week, two studies provided big insights into brain changes and specific genetic sites and risk factors for Alzheimer’s disease. For those and more, continue reading.
-
Cytovia Therapeutics partners with Inserm to develop selective CD38 NK therapeutics and offer new treatment options for Multiple Myeloma patients
10/8/2020
Cytovia Therapeutics, an emerging biopharmaceutical company, announces that it has entered a research and licensing agreement with Inserm to develop NK engager bi-specific antibodies and iPSC CAR NK cell therapy targeting CD38, a key marker of multiple myeloma.
-
TxCell And INSERM Collaborate To Develop New CAR-Tregs In Transplantation And Multiple Sclerosis
5/2/2017
-
Here's More Evidence That Brain Fatigue Makes Us Do Dumb Things, INSERM Study
6/30/2016
-
INSERM Release: French Research Team Helps Extend MRI Detection Of Diseases & Lower Health-Care Costs
6/21/2016
-
Dassault Systèmes And INSERM Announce Joint Agreement To Decipher Disease Complexity And Accelerate Clinical Research
3/29/2016
-
Being Anxious Could Be Good For You -- In A Crisis, INSERM Study
12/29/2015
-
Strategic Partnership Between Pierre Fabre And INSERM In Immuno-Oncology
12/14/2015
-
Intelligent Bacteria For Detecting Disease, INSERM Study
6/4/2015
-
Viagra To Prevent Transmission Of The Malaria Parasite? INSERM Study
5/8/2015
-
Quest Diagnostics And INSERM Launch Multinational BRCA Gene Datashare Initiative, With LabCorp As First Participant, To Improve The Detection Of Inherited Risk Of Breast And Ovarian Cancers
4/21/2015
-
An Electronic Micropump To Deliver Treatments Deep Within The Brain, INSERM Study
4/17/2015
-
Advanced Biological Laboratories SA (ABL) Enters Into Worldwide Exclusive License Agreement For HIV Tropism Determination Technology With INSERM And Inserm Transfert SA, And The Centre Hospitalier Universitaire De Toulouse
1/26/2015
-
Abzena Subsidiary Antitope, INSERM And Baylor Institute For Immunology Research To Collaborate To Produce Manufacturing Cell Lines For Two Novel Vaccines For HIV
1/12/2015
-
Blood Type May Raise Diabetes Risk, INSERM Study
12/22/2014
-
Why Does The Brain Remember Dreams? INSERM Study
2/19/2014
-
The Science Of The Munchies After Pot Use Uncovered, INSERM Study
2/12/2014
-
La Jolla Pharmaceutical Company And INSERM, Inserm Transfert Announce License Agreement to Develop Hepcidin Agonists
2/11/2014
-
Meat Products Could Raise Diabetes Risk, INSERM Study
11/13/2013